Drug-resistant cancer responds to personalized drug combinations

Drug-resistant cancer responds to personalized drug combinations

Cancer researcher and physician Jeffrey Engelman of the Massachusetts General Hospital in Boston has found a promising way of treating drug-resistant cancer by growing patients’ tumor cells and testing various drug combinations on them to find a way of effective treatment. Engelman and his colleagues devised a way to culture lung cancer cells from patient samples and then test them against a battery of 76 different drugs; and they got encouraging results. According to the researcher, this cell-culture model could make personalized drug screening swifter as compared to using a mouse model. However, the team reported that they got unexpected results during their probe; for example, cell samples that were resistant to therapies targeting a protein called ALK were felled by different drugs that inhibited another protein called SRC. Further research is required before this treatment can be used for patients.

Read more in Nature.    

Related video: beauty in different cultures essay

Leave a Reply

Your email address will not be published. Required fields are marked *